Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Lies and LAIs: why accuracy of information is the key to understanding the benefits and the resistance to using long-acting formulation.
Journal: CNS spectrums
Published: December 19, 2025
Pharmacokinetic evaluation of aripiprazole monohydrate as a once every 2-months long-acting injectable antipsychotic for schizophrenia.
Journal: Expert opinion on drug metabolism & toxicology
Published: August 08, 2025
What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination.
Journal: The Journal of clinical psychiatry
Published: June 09, 2025
Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: April 22, 2025
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms.
Journal: Schizophrenia bulletin open
Published: February 28, 2025
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication Satisfaction.
Journal: Schizophrenia bulletin open
Published: February 28, 2025
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: October 16, 2024
Initiating Aripiprazole Lauroxil: Post Hoc Analysis of Safety and Tolerability of 1-Day and 21-Day Regimens.
Journal: The Journal of clinical psychiatry
Published: August 15, 2024
Safety and tolerability of KarXT (xanomeline-trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia.
Journal: Schizophrenia (Heidelberg, Germany)
Published: September 08, 2022
Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic.
Journal: Trends in pharmacological sciences
Published: August 12, 2022
Antipsychotic Efficacy of KarXT (Xanomeline-Trospium): Post Hoc Analysis of Positive and Negative Syndrome Scale Categorical Response Rates, Time Course of Response, and Symptom Domains of Response in a Phase 2 Study.
Journal: The Journal of clinical psychiatry
Published: May 13, 2022
Handwriting Kinematics in Patients with Schizophrenia Treated with Long-Acting Injectable Atypical Antipsychotics: Results From the ALPINE Study.
Journal: Schizophrenia bulletin open
Published: March 07, 2022
Last Updated: 09/26/2026